Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin and Total Lymphoid Irradiation Followed by Allogeneic Hematopoietic Stem Cell Transplantation

NCT00697684 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00697684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin and Total Lymphoid Irradiation Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2008
Completion date
November 30, 2023
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myeloid leukemia, hodgkins disease, myelodysplastic syndrome, relapsed refractory multiple myeloma, relapsed/refractory chronic lymphocytic leukemia, relapsed/refractory non hodgkin's lymphoma